HIGHLIGHTS
- who: Zachary A. Kipp et al. from the Department of Pharmacology and Nutritional Sciences, University of Kentucky, Press Healthy Kentucky Research Building, Lexington, KY, USA have published the paper: Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content, in the Journal: Metabolites 2023, 215 of 30/01/2023
- what: In Figure 2b, show the authors show lipid species were significantlydifferent, different,with with species. This study demonstrated for the first time that bilirubin nanoparticles modified the hepatic lipid pool by increasing the amount of phosphatidylethanolamine and inhibiting the accumulation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.